Baker Brothers Advisors - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2021$2,646,000
-62.2%
461,726
-41.0%
0.01%
-57.7%
Q4 2020$6,993,000
+30.2%
782,183
+69.6%
0.03%
+23.8%
Q3 2020$5,370,000
-31.0%
461,324
-5.0%
0.02%
-38.2%
Q2 2020$7,785,000
+729.1%
485,624
+209.8%
0.03%
+466.7%
Q1 2020$939,000
-54.6%
156,7730.0%0.01%
-45.5%
Q4 2019$2,069,000
+6.3%
156,7730.0%0.01%
-15.4%
Q3 2019$1,947,000
-22.9%
156,7730.0%0.01%
-23.5%
Q2 2019$2,524,000
-48.8%
156,7730.0%0.02%
-46.9%
Q1 2019$4,934,000
-4.2%
156,7730.0%0.03%
-23.8%
Q4 2018$5,148,000
-28.7%
156,773
-33.4%
0.04%
-12.5%
Q3 2018$7,216,000
+14.5%
235,2940.0%0.05%
+2.1%
Q2 2018$6,304,000235,2940.05%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,530,657$23,126,0001.85%
TFG Asset Management GP Ltd 2,500,000$16,375,0001.00%
Nantahala Capital Management 2,936,791$19,236,0000.61%
MYDA Advisors LLC 171,953$1,126,0000.32%
SABBY MANAGEMENT, LLC 300,000$1,965,0000.27%
Regency Capital Management Inc.\DE 57,000$373,0000.26%
Ikarian Capital, LLC 544,819$3,568,0000.25%
Eversept Partners, LP 398,074$2,607,3850.18%
Henry James International Management Inc. 54,047$354,0000.11%
Alphabet Inc. 698,262$4,574,0000.11%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders